85 related articles for article (PubMed ID: 22059804)
1. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma.
Diessl S; Holzberger B; Mäder U; Grelle I; Smit JW; Buck AK; Reiners C; Verburg FA
Clin Endocrinol (Oxf); 2012 Apr; 76(4):586-92. PubMed ID: 22059804
[TBL] [Abstract][Full Text] [Related]
2. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
[TBL] [Abstract][Full Text] [Related]
3. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
[TBL] [Abstract][Full Text] [Related]
4. The role of thyrotropin suppression in patients with differentiated thyroid carcinoma.
Deasy J; Prichard RS; Evoy D; McDermott EW
Ir Med J; 2010; 103(7):202-5. PubMed ID: 20845598
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
6. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.
De Pergola G; Ciampolillo A; Paolotti S; Trerotoli P; Giorgino R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):265-9. PubMed ID: 17547687
[TBL] [Abstract][Full Text] [Related]
7. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of a sensitive thyrotrophin assay in the fine adjustment of thyroxine therapy following ablation for carcinoma.
de Lange WE; Sluiter WJ; Doorenbos H
Neth J Med; 1989 Aug; 35(1-2):11-7. PubMed ID: 2779691
[TBL] [Abstract][Full Text] [Related]
10. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer.
Mann K; Saller B; Mehl U; Hörmann R; Moser E
Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
13. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.
Pujol P; Daures JP; Nsakala N; Baldet L; Bringer J; Jaffiol C
J Clin Endocrinol Metab; 1996 Dec; 81(12):4318-23. PubMed ID: 8954034
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
Mikosch P; Igerc I; Kudlacek S; Woloszczuk W; Gallowitsch HJ; Kresnik E; Stettner H; Grimm G; Lind P; Pietschmann P
Eur J Clin Invest; 2006 Aug; 36(8):566-73. PubMed ID: 16893379
[TBL] [Abstract][Full Text] [Related]
15. [Hormone therapy as postoperative care in patients with differentiated thyroid cancer].
Kurihara H; Kuwahara T; Nakano Y
Nihon Geka Gakkai Zasshi; 1987 Oct; 88(10):1415-22. PubMed ID: 3696136
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
18. The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.
Verburg FA; Mäder U; Grelle I; Visser TJ; Peeters RP; Smit JW; Reiners C
Horm Metab Res; 2014 Oct; 46(11):794-9. PubMed ID: 24867137
[TBL] [Abstract][Full Text] [Related]
19. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the release of thyroid hormones in septic shock--prognostic significance].
Borkowski J; Siemiatkowski A; Wołczyński S; Czaban SL; Jedynak M
Pol Merkur Lekarski; 2005 Jan; 18(103):45-8. PubMed ID: 15859546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
